Alseres Pharmaceuticals, Inc. (ALSE.PK)
ALSE.PK on USA Pink Sheets
0.25USD
8 Feb 2010
0.25USD
8 Feb 2010
Price Change (% chg)
$0.00 (+0.00%)
$0.00 (+0.00%)
Prev Close
$0.25
$0.25
Open
--
--
Day's High
$0.25
$0.25
Day's Low
$0.25
$0.25
Volume
15,900
15,900
Avg. Vol
2,515
2,515
52-wk High
$2.00
$2.00
52-wk Low
$0.19
$0.19
ALSE.PK
About
Alseres Pharmaceuticals, Inc. (Alseres Pharmaceuticals) is a biotechnology company. The Company is engaged in the development of therapeutic and diagnostic products primarily for disorders in the central nervous system (CNS). The Company's clinical and preclinical product candidates are based on three technology platforms:... (more)
No analyst recommendations are available for ALSE.PK.
Overall
| Beta: | 0.29 |
| Market Cap (Mil.): | $6.39 |
| Shares Outstanding (Mil.): | 25.56 |
| Annual Dividend: | 0.00 |
| Yield (%): | NA |
Financials
| ALSE.PK | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 11.50 | 3.76 |
| EPS (TTM): | 43.64 | -- | -- |
| ROI: | -- | 1.25 | 2.30 |
| ROE: | -- | 2.09 | 2.82 |
Competitors
| Price | Change | |
|---|---|---|
| General Electric Company (GE.N) | $15.64 | +0.04 |
Earnings vs 
Estimates
No consensus analysis data available.
© Copyright 2010 Thomson Reuters
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
